Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 31

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 31
---
 EP 
    Pending 
      
    15865264.4 
    02-Dec-2035*
  
    Novel Regimens Of Tafenoquine For Prevention Of Malaria In
    Malaria-Naïve Subjects 
    Pending 
    Hong Kong 
    Pending 
      
    18103081.4 
    02-Dec-2035*

13

Title 
    Patent No. 
    Country 
    Status 
    US Patent
    Date 
    Application 
    No. 
    Estimated/
    Anticipated Expiration Date

    Regimens Of Tafenoquine For Prevention Of Malaria In Malaria-Naive
    Subjects 
    11,744,828 
    US 
      
     9/5/2023 
    17/145,530 
    02-Dec-2035^
  
    Novel Regimens Of Tafenoquine For Prevention Of Malaria In
    Malaria-Naïve Subjects 
    Pending 
    New Zealand 
    Pending 
      
    731813 
    02-Dec-2035*
  
    Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive
    Subjects 
    Pending 
    US 
    Pending 
      
    18/240,049 
    02-Dec-2035^
  
    Novel Dosing Regimens Of Celgosivir For The Prevention Of Dengue 
    2016368580 
    Australia 

    2016368580 
    09-Dec-2036*
  
    Novel Dosing Regimens Of Celgosivir For The Prevention Of Dengue 
    Pending 
    Singapore 
    Pending 
      
    10201912141Y 
    09-Dec-2036*
  
    Dosing Regimens Of Celgosivir For The Prevention Of Dengue 
    11000516 
    US 
      
     5/11/2011 
    16/060,945 
    09-Dec-2036^
  
    Methods For The Treatment And Prevention Of Lung Infections
    By Administration Of Tafenoquine 
    Pending 
    EP 
    Pending 
      
    21764438.4 
    02-Mar-2041*
  
    Methods For The Treatment And Prevention Of Lung Infections
    By Administration Of Tafenoquine 
    Pending 
    China